Scientific Session: Investigating New Drug Candidates for Immune Thrombocytopenia

Speaker

Dr. Alan Lazarus
Scientist, Keenan Research Center for Biomedical Science and Canadian Blood Services Center for Innovation

Objectives

1. Learn the pathophysiological mechanisms of platelet destruction in ITP
2. Review the mechanisms of action of syk inhibitors may improve platelet count in some patients with ITP.
3. Review review recent efforts at replacing IVIg with recombinant reagents including work from the investigators lab.

To register for the event visit  LearnTransfusion series .
The LearnTransfusion series is the seminar of the  Areas of Focused Competency (AFC) -Diploma Program in Transfusion Medicine . The series, organized by Canadian Blood Services, is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.